Literature DB >> 18453617

Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice.

Alexander Riad1, Sebastian Jäger, Meike Sobirey, Felicitas Escher, Aymaru Yaulema-Riss, Dirk Westermann, Aysun Karatas, Markus M Heimesaat, Stefan Bereswill, Duska Dragun, Matthias Pauschinger, Heinz P Schultheiss, Carsten Tschöpe.   

Abstract

Left ventricular (LV) remodeling is known to contribute to morbidity and mortality after myocardial infarction (MI). Because LV remodeling is strongly associated with an inflammatory response, we investigated whether or not TLR-4 influences LV remodeling and survival in a mice model of MI. Six days after MI induction, TLR4 knockout (KO)-MI mice showed improved LV function 32 and reduced LV remodeling as indexed by reduced levels of atrial natriuretic factor and total collagen as well as by a reduced heart weight to body weight ratio when compared with WT-MI mice. This was associated with a reduction of protein levels of the intracellular TLR4 adapter protein MyD88 and enhanced protein expression of the anti-hypertrophic JNK in KO-MI mice when compared with wild-type (WT)-MI mice. In contrast, protein activation of the pro-hypertrophic kinases protein kinase Cdelta and p42/44 were not regulated in KO-MI mice when compared with WT-MI mice. Improved LV function, reduced cardiac remodeling, and suppressed intracellular TLR4 signaling in KO-MI mice were associated with significantly improved survival compared with WT-MI mice (62 vs 23%; p < 0.0001). TLR4 deficiency led to improved survival after MI mediated by attenuated left ventricular remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18453617     DOI: 10.4049/jimmunol.180.10.6954

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.

Authors:  Jamie C Zampell; Sonia Elhadad; Tomer Avraham; Evan Weitman; Seth Aschen; Alan Yan; Babak J Mehrara
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-02       Impact factor: 4.249

Review 2.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 3.  Therapeutic targeting of innate immunity in the failing heart.

Authors:  Veli K Topkara; Sarah Evans; Weili Zhang; Slava Epelman; Lora Staloch; Philip M Barger; Douglas L Mann
Journal:  J Mol Cell Cardiol       Date:  2010-11-10       Impact factor: 5.000

4.  Variants of Toll-like receptor 4 predict cardiac recovery in patients with dilated cardiomyopathy.

Authors:  Alexander Riad; Henriette Meyer zu Schwabedissen; Kerstin Weitmann; Lars R Herda; Marcus Dörr; Klaus Empen; Arne Kieback; Astrid Hummel; Marcus Reinthaler; Marcus Grube; Karin Klingel; Matthias Nauck; Reinhard Kandolf; Wolfgang Hoffmann; Heyo K Kroemer; Stephan B Felix
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 5.  Toll-like receptors: new players in myocardial ischemia/reperfusion injury.

Authors:  Tuanzhu Ha; Li Liu; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  Antioxid Redox Signal       Date:  2011-04-08       Impact factor: 8.401

6.  Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis.

Authors:  Nian Wan; Xiaoxiong Liu; Xiao-Jing Zhang; Yichao Zhao; Gangying Hu; Fengwei Wan; Rui Zhang; Xueyong Zhu; Hao Xia; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

Review 7.  Regulation of wound healing and organ fibrosis by toll-like receptors.

Authors:  Peter Huebener; Robert F Schwabe
Journal:  Biochim Biophys Acta       Date:  2012-12-04

Review 8.  Recent advances of adapter proteins in the regulation of heart diseases.

Authors:  Li Tao; Linna Jia; Yuntian Li; Chengyun Song; Zheng Chen
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

Review 9.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

Review 10.  Post-infarct remodelling: contribution of wound healing and inflammation.

Authors:  Stefan Frantz; Johann Bauersachs; Georg Ertl
Journal:  Cardiovasc Res       Date:  2008-10-31       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.